SCHEMBL13745651

SCHEMBL13745651

Cc1ccc(CNC(=O)C2CCNCC2)cc1

nearest known ligand 0.72

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.72
▸ SMN1; SMN2 Q16637 2/20 0.72
▸ TSHR P16473 2/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ HTR2C P28335 1/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ USP2 O75604 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23774080 0.89 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TSHRCYP3A4TDP1
SCHEMBL13746002 0.88 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2TSHRCYP3A4HTR2C
SCHEMBL20088437 0.86 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2LMNAHTR2CMEN1
SCHEMBL17476862 0.86 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2TSHRCYP3A4TDP1
SCHEMBL10195738 0.86 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2TSHRCYP3A4TDP1
SCHEMBL172079 0.85 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CMEN1KMT2A
SCHEMBL4037264 0.85 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TSHRCYP3A4LMNA
SCHEMBL526330 0.84 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2TSHRHTR2CUSP2
SCHEMBL13745650 0.84 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2TSHRTDP1LMNA
SCHEMBL4035763 0.84 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2CYP3A4LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009098282-A1 LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY NOVASAID AB (SE) 2009-08-13 — — WO disclosed
Send feedback